The Latest Cardiac and Vascular News
InsiteOne will continue to develop and support BRIT Systems RIS/PACS while building new solutions that address key needs in radiology and enterprise workflows. WALLINGFORD, Conn., Nov. 21, 2023 /PRNewswire/ — InsiteOne, an original founder of true cloud-based Vendor Neutral Archive (VNA)…
CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics today announced the publication of its groundbreaking study in the Journal of the American Heart Association (JAHA),
DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced the presentation of positive V005 Phase 2/3 clinical trial results of the investigational Human Acellular Vessel (HAV) in the treatment of vascular trauma, […]
SAN MATEO, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced it has raised over $31 million in a Series F financing to accelerate the commercial adoption of a neurovascular intervention […]
Registry Intends to Examine Contemporary On-Label Use of the MANTA™ Vascular Closure Device Including Appropriate Patient Selection and Proper Vascular Access WAYNE, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical registry […]
LONDON, Nov. 16, 2023 /PRNewswire/ — Founder and CEO of CardioThrive, Shelley Savage has dedicated her career to saving lives. Her company’s patented invention, the PocketDefib™, has the potential to dramatically reduce the number of deaths caused by SCA (Sudden cardiac arrest) all over…
FORT COLLINS, Colo., Nov. 15, 2023 (GLOBE NEWSWIRE) — Enlitic®, a pioneering force in the realm of medical imaging data management, is gearing up for its participation in the Radiological Society of North America (RSNA) Annual Scientific Assembly and Meeting 2023. Enlitic is entering this year’s meeting with an unwavering […]
Patients undergoing non-invasive treatment show significant improvement in frequency of chest pain, exercise capacity and quality-of-life markers FORT WORTH, Texas, Nov. 15, 2023 /PRNewswire/ — Enhanced External Counterpulsation (EECP®), a non-invasive treatment that increases blood…
Multicenter clinical study showcases how Tenzing® technology is improving neurovascular intervention outcomes SAN MATEO, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced compelling results from a multicenter clinical study1 on the […]
CINCINNATI–(BUSINESS WIRE)–LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company developing Lerodalcibep, a novel, third-generation PCSK9 inhibitor for patients at very high and high risk of cardiovascular disease (CVD), today announced completion of LIBerate-CVD and LIBerate-HR, the final two registration-enabling Phase 3 trials for patients with CVD or at very high and high risk of CVD. These two trials are part of the registration-enabling Phase 3 LIBerate Pro
